ArticleiScience2025
Coronary computed tomography angiography plaque and flow patterns in acute coronary syndrome lesions.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute coronary syndrome (ACS) risk stratification requires assessment across different time frames. This multicenter study investigated whether a single coronary computed tomography angiography (CCTA) scan could provide integrated short-term (≤7 days) and long-term (≥30 days) risk assessment. The study developed and validated dual-timeframe models combining population health data, stenosis severity, quantitative low-density plaque burden (LDP%), and the hemodynamic parameter ΔCT-FFR (CT-derived fractional flow reserve [CT-FFR] proximal to the lesion minus CT-FFR distal to the lesion). Key findings indicate that while stenosis and LDP% predicted ACS risk in both time frames, ΔCT-FFR was specifically associated with short-term risk. The combined models demonstrated superior performance and greater net clinical benefit compared to using stenosis severity alone, as confirmed in multiple external cohorts. These results establish that a single CCTA examination can simultaneously assess immediate and future ACS risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.